Literatura científica selecionada sobre o tema "Kaposi's disease"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Kaposi's disease".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Kaposi's disease"
Santos, Mônica, Virginia Vilasboas, Luciana Mendes, Carolina Talhari e Sinésio Talhari. "Lymphangiectatic Kaposi's sarcoma in a patient with AIDS". Anais Brasileiros de Dermatologia 88, n.º 2 (abril de 2013): 276–78. http://dx.doi.org/10.1590/s0365-05962013000200019.
Texto completo da fonteMurthy MS, Cody Lawrence, Todd Brown e Shanika Sharma. "Presence of Kaposi's Sarcoma and of Behcet’s Disease Concomitantly in a Patient". International Healthcare Research Journal 6, n.º 12 (12 de março de 2023): RV1—RV3. http://dx.doi.org/10.26440/ihrj/0611.02591.
Texto completo da fonteGrabovskaya, Olga V., Natalia P. Teplyuk, Sergey A. Mishin, Ekaterina V. Grekova, Ekaterina R. Dunaeva, Alina V. Perekhodova e Lidia M. Shnakhova. "Kaposi's sarcoma: Problems of differential diagnosis". Russian Journal of Skin and Venereal Diseases 26, n.º 5 (17 de novembro de 2023): 487–95. http://dx.doi.org/10.17816/dv492311.
Texto completo da fonteCorda, L., D. Benerecetti, M. Ungari, F. Facchetti e E. Radaeli. "Kaposi's disease and sarcoidosis". European Respiratory Journal 9, n.º 2 (1 de fevereiro de 1996): 383–85. http://dx.doi.org/10.1183/09031936.96.09020383.
Texto completo da fonteOLIVEIRA, H., C. MONTEIRO e A. FIGUEIREDO. "FC135 Iatrogenic Kaposi's disease". Journal of the European Academy of Dermatology and Venereology 9 (setembro de 1997): S147. http://dx.doi.org/10.1016/s0926-9959(97)89456-1.
Texto completo da fonteKoyuncu, Ismail, Ataman Gönel, Emrah Ozcan, Ebru Temiz, Şahin Toprak, Feridun Akkafa e Irfan Binici. "Single Nucleotide Polymorphism Analysis in HIV and Kaposi's Sarcoma Disease by Microarray Technique". Current HIV Research 18, n.º 3 (12 de junho de 2020): 154–64. http://dx.doi.org/10.2174/1570162x18666200130100654.
Texto completo da fonteGrishina, E. E. "Kaposi’s sarcoma with the eyelid involvement (6 clinical cases)". Almanac of Clinical Medicine 46, n.º 4 (26 de setembro de 2018): 390–94. http://dx.doi.org/10.18786/2072-0505-2018-46-4-390-394.
Texto completo da fonteSterling, Glenn B. "Kaposi's sarcoma and Castleman's disease". Journal of the American Academy of Dermatology 22, n.º 1 (janeiro de 1990): 144. http://dx.doi.org/10.1016/s0190-9622(08)80030-8.
Texto completo da fonteKoldarova, Evelina, Bahrambek Mukhamedov e Aziz Aliev. "A clinical case of an immunosuppressive generalized form of Kaposi's sarcoma in a patient with pemphigus vulgaris". Journal of Clinical Medicine of Kazakhstan 19, n.º 6 (30 de dezembro de 2022): 100–103. http://dx.doi.org/10.23950/jcmk/12695.
Texto completo da fonteSteinfeld, AD, e JS Cooper. "Epidemic and classic Kaposi's sarcoma of the feet. A comparative study". Journal of the American Podiatric Medical Association 80, n.º 9 (1 de setembro de 1990): 469–70. http://dx.doi.org/10.7547/87507315-80-9-469.
Texto completo da fonteTeses / dissertações sobre o assunto "Kaposi's disease"
Wiggins, Charles Lamar. "Kaposi's sarcoma and sexually transmitted disease /". Thesis, Connect to this title online; UW restricted, 1999. http://hdl.handle.net/1773/10933.
Texto completo da fonteKimball, Louise Elizabeth. "Humoral immune response to Kaposi's sarcoma-associated herpesvirus in persons with and without Kaposi's sarcoma /". Thesis, Connect to this title online; UW restricted, 2003. http://hdl.handle.net/1773/9284.
Texto completo da fonteHong, Angela M. "Cell cycle protein expression in AIDS-related and classical Kaposi's sarcoma". Connect to full text, 2004. http://hdl.handle.net/2123/583.
Texto completo da fonteTitle from title screen (viewed 5 May 2008). Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy to the Faculty of Medicine. Includes list of published articles and presentations. Includes bibliographical references. Also available in print form.
Kakoola, Dorothy Nalwanga. "Human herpesvirus 8 in Uganda : seroprevalence in blood donors, genome variability and evolution". Thesis, University of Glasgow, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.366192.
Texto completo da fonteSpeicher, David Jeremiah. "Detection and Genotyping of HHV-8 in Australia and Kenya: Disease Associations with Special reference to Kaposi's Sarcoma and Castleman's Disease". Thesis, Griffith University, 2012. http://hdl.handle.net/10072/367862.
Texto completo da fonteThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Dentistry and Oral Health
Griffith Health
Full Text
Blumenthal, Melissa. "Characterisation of Kaposi's sarcoma-associated herpesvirus (KSHV)-driven pathology and disease outcome in HIV infected South African patients". Doctoral thesis, Faculty of Health Sciences, 2020. http://hdl.handle.net/11427/32202.
Texto completo da fonteMagri, Mariana Cavalheiro. "Prevalência de anticorpos anti-herpesvírus humano tipo 8 (HHV-8) em soros de pacientes com insuficiência renal crônica". Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-25072008-144452/.
Texto completo da fonteHuman herpesvirus 8 (HHV-8) infection is frequently associated with Kaposi\'s sarcoma (KS) in immunodeficient and renal transplanted patients. The HHV-8 seroprevalence in healthy populations varies from 1% to 8%. The present study aimed to determine the HHV-8 seroprevalence and antibodies titers in chronic kidney disease (CKD) patients with or without substitutive kidney therapy (SKT) attended at Hospital do Rim e Hipertensão and Casa da Diálise of UNIFESP, and at Santa Casa de Misericórdia de São Paulo. Secondarly, to compare the serological results with those obtained from populations of the same geographic region, presenting other risk factors for acquiring infectious diseases. Serum samples were collected from 805 CKD patients: 295 under hemodialysis, 54 under peritoneal dialysis, and 456 in ambulatorial assistance without SKT. Latent and Lytic HHV-8 antibodies were searched using indirect immunofluorescence assays that were standardized at Immunology Department of Instituto Adolfo Lutz. Chi-Square test and/or Fisher\'s exact test were performed for comparing categorical variables including epidemiological, clinical and laboratorial data, and HHV-8 serum status. Continuos variables associated with HHV-8 antibodies titers were compared using Mann Whitney or Kruskal Wallis tests. An overall HHV-8-seropositivity of 18.0% was detected in CKD patients: 18.3% in patients under SKT and 17.7% in patients without SKT. Since no difference was detected in HHV-8-seropositivity among patients, they were considered as a unique group for subsequent analysis. A strong association between HHV-8-seropositivity and previous transplant was detected (p<0.001), along with an association with others sexually transmitted diseases (p=0.003), with emphasis for syphilis (p=0.021). In addition, no other data was associated with HHV-8-seropositivity, although higher proportions of HHV-8-seropositivity were detected in samples from elderly persons. In addition, more HHV-8 Lytic antibodies positive samples, and higher titers of LANA antibodies were detected. HHV-8 seroprevalence obtained from CKD patients was similar to the HHV-8 prevalence detected among HIV/Aids patients (20.4%), who were considered a high-risk group for this viral infection. On the other hand, the HHV-8 seroprevalence of CKD patients (18.0%) was lower than the prevalence of patients with epidemic KS (89.3%), classic KS (100.0%) and endemic KS (87.5%), and higher than the patients with mental and/or physical deficiency (1.6%) and health professionals (1.1%). All analyzed groups had more HHV-8-seropositive samples for Lytic antibodies and higher titers of LANA antibodies, with exception for the health professionals. The highest LANA antibodies titers were found among KS patients groups. No other association was found. In conclusion, the obtained results points out CKD patients as a high prevalent population for HHV-8 infection, similar to HIV/Aids patients from the same geographic area. As far, it suggests that HHV-8 seropositive CKD patients should be followed up in order to verify whether LANA antibodies titers have prognostic value. In confirming this hypothesis, it may propose to include the use of HHV-8 serology in the screening testing in kidney pre-transplant.
Kohlhorst, Drew Eric. "Bartonella Bacilliformis: Understanding The Underlying Causes Of Verruga Peruana Formation During Carrion’s Disease". Digital Archive @ GSU, 2008. http://digitalarchive.gsu.edu/biology_diss/37.
Texto completo da fonteViollet, Coralie. "Dissecting the interactive effects of hypoxia and Kaposi's sarcoma-associated herpesvirus on microRNA and mRNA transcriptomes". Thesis, University of Oxford, 2015. http://ora.ox.ac.uk/objects/uuid:602498b1-f1fb-4677-be91-14dd5add728b.
Texto completo da fonteBailer, Robert T. "Human T-lymphotrophic virus types I/II in autoimmune diseases, growth characteristics and cytokine expression in AIDS-related Kaposi's sarcoma derived cell strains and patients, and constitutive cytokine expression in HTLV and STLV.. /". The Ohio State University, 1994. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487856076415404.
Texto completo da fonteLivros sobre o assunto "Kaposi's disease"
J, Gottlieb Geoffrey, e Ackerman A. Bernard 1936-, eds. Kaposi's sarcoma: A text and atlas. Philadelphia: Lea & Febiger, 1988.
Encontre o texto completo da fonteG, Giraldo, ed. Recent advances in AIDS and Kaposi's sarcoma. Basel: Karger, 1987.
Encontre o texto completo da fonteLehnherr, Melinda. Kaposi's sarcoma in Illinois: A comparison of AIDS cases to classic cases. Springfield, Ill: Illinois Dept. of Public Health, Division of Epidemiologic Studies, 1989.
Encontre o texto completo da fonteG, Castello, ed. Sindrome di immunodeficienza acquisita e sarcoma di Kaposi (AIDS/KS). Firenze: USES, Edizioni scientifiche, 1986.
Encontre o texto completo da fonteShepherd, Frances A. Management of Kaposi's sarcoma associated with human immunodeficiency virus infection: Report. [Ottawa]: Health and Welfare Canada, 1991.
Encontre o texto completo da fonteCanada. Health and Welfare Canada. Management of Kaposi's Sarcoma associated with human immunodeficiency virus infection/ Francis A. Shepard. Ottawa: Health and Welfare Canada, 1991.
Encontre o texto completo da fonteG, Giraldo, World Health Organization e International Symposium on AIDS and Associated Cancers in Africa (2nd : 1987 : Naples, Italy), eds. AIDS and associated cancers in Africa: 2nd international symposium, Naples, October 7-9, 1987. Basel: Karger, 1988.
Encontre o texto completo da fonte1925-, Vaeth Jerome M., ed. Cancer and AIDS: 19th annual San Francisco Cancer Symposium, San Francisco Calif., March 2-4, 1984. Basel: Karger, 1985.
Encontre o texto completo da fonteAIDS, the acquired immune deficiency syndrome. 2a ed. Lancaster [Lancashire]: MTP Press, 1987.
Encontre o texto completo da fonteDaniels, Victor G. SIDA, sindrome de immunodeficiencia adquirida. 2a ed. México: Manual Moderno, 1988.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Kaposi's disease"
Vaccaro, Mario, Claudio Guarneri, Richard F. Ambinder, S. Diane Hayward, Marcia Spinelli Casanova, Oladapo Adewuya, Ferid Murad et al. "Kaposi’s Sarcoma". In Encyclopedia of Molecular Mechanisms of Disease, 1110–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_992.
Texto completo da fonteTschachler, Erwin. "Kaposi’s Sarcoma". In Sexually Transmitted Infections and Sexually Transmitted Diseases, 405–9. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-14663-3_31.
Texto completo da fonteCrowe, David R. "Kaposi Sarcoma". In Deadly Dermatologic Diseases, 61–66. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-31566-9_9.
Texto completo da fonteChung, Christina Lee, e Carla Ferrándiz-Pulido. "Kaposi Sarcoma". In Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients, 367–87. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-13335-0_15.
Texto completo da fonteMoore, Patrick S., e Yuan Chang. "Introduction to Diseases Associated with Kaposi’s Sarcoma-Associated Herpesvirus". In DNA Tumor Viruses, 441–68. New York, NY: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-68945-6_18.
Texto completo da fonteItakura, Hideyo, e Kan Toriyama. "Geopathological Coincidence of Burkitt’s Lymphoma and Endemic Kaposi’s Sarcoma in Western Kenya". In Epstein-Barr Virus and Human Disease, 453–54. Totowa, NJ: Humana Press, 1987. http://dx.doi.org/10.1007/978-1-4612-4590-2_97.
Texto completo da fontePoudyal, Rosha, Rolf Renne e Michael P. Kladde. "Epigenetic Regulation of Gammaherpesviruses: A Focus on Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8)". In Epigenetics of Infectious Diseases, 15–46. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-55021-3_2.
Texto completo da fonteGoh, Yet Ching. "Reddish Growths on the Hard Palate: Kaposi Sarcoma". In Clinicopathological Correlation of Oral Diseases, 141–49. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24408-7_13.
Texto completo da fonteDittmer, Dirk P., e Blossom Damania. "Kaposi’s Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update". In Cancer Treatment and Research, 63–80. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-030-03502-0_3.
Texto completo da fonteCesarman, Ethel. "The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases". In Immunosurveillance, Immunodeficiencies and Lymphoproliferations, 27–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-642-56352-2_4.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Kaposi's disease"
Lefrere, J. J., D. Vittecoq, D. Gozin e J. Modai. "CIRCULATING ANTICOAGULANT IN AIDS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644859.
Texto completo da fonteEverstine, A., e M. E. Richert. "Overcoming the Cytokine Storm: Unusual Case of Kaposi Sarcoma Herpes-Associated Multicentric Castleman Disease". In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7492.
Texto completo da fonteQin, Zhiqiang, Lu Dai, Momka Bratoeva, Bryan Toole e Chris Parsons. "Abstract LB-435: Regulation of emmprin in Kaposi's sarcoma-associated herpesvirus (KSHV)-infected cells: a novel strategy developed against KSHV-related diseases". In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-435.
Texto completo da fonte